No Data
No Data
Avadel Pharmaceuticals Announces Publication of Findings on Sodium Oxybate
Avadel Pharmaceuticals Presents Results From Social Listening Analysis And Survey Of People With Narcolepsy Uncover Real-Life Challenges With Twice-Nightly Oxybate Therapy
Insider Purchase: Director at $AVDL (AVDL) Buys 3,000 Shares
Avadel Chief Commercial Officer Resigns, Stock Down 14%
UBS Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Cuts Target Price to $22
US Manufacturing Index Rises To 43, Highest Since 2020